COVID-19

A recent study shows teenagers' mental health and brain maturation increased due to the effects of the COVID-19 pandemic.

Less than half (45%) of all nursing facility residents and less than a quarter of staff (22%) are up to date with their COVID-19 vaccinations. That is a sharp drop from the 87% of nursing facility residents and staff who completed their primary vaccination series.

The US Food and Drug Administration has updated the emergency use authorization for bivalent COVID-19 vaccines to be available for children aged 6 months and older.

Two clinical pathways were created to manage patients and required resources.

A new analysis suggests those with an increased body mass index and women were more likely to experience long COVID

Providing culturally competent care is one way pharmacists can help improve vaccine uptake in their communities.

Sydney Kirkpatrick, PharmD candidate, shares how pharmacy helped ease the burden of COVID-19 in rural areas of Nebraska.

Take a look back at our most popular COVID-19 coverage for 2022.

In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.

CVS is the first pharmacy to offer this service nationwide.

With closing remarks, Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, discuss common myths circulating around COVID-19 vaccines and vaccination.

Expert panelists highlight special considerations when selecting COVID-19 vaccines.

A real-world study determined the efficacy of mRNA vaccines for protection against COVID-19 in adolescents.

Although initial infection of the virus has resulted in risk of hospitalization and mortality, researchers looked into the effects of reinfection as data has been unclear.

Compared to the original mRNA-1273 booster dose, the bivalent booster mRNA -1273.222 was superior against Omicron variants.

Communication and education are critical to patient confidence in emergency use authorization vaccines.

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share thoughts on COVID-19 vaccines and boosters in anticipation of an uptick in cases in the coming months.

Key opinion leaders share insights regarding considerations for COVID-19 boosters amid variants.

Addressing hesitancy is more than just offering pertinent information.

Experts discuss comorbidities as risk factors for patients developing severe COVID-19 symptoms.

Medical experts discuss potential long-term adverse effects associated with COVID-19.

Drs Rothholz and Goad discuss population health strategies for COVID-19.

Pharmacists play a significant role in patient education regarding COVID-19 vaccines.

Mitchel Rothholz, RPh, MBA, and Jeff Goad, PharmD, MPH, share insights regarding COVID-19 potentially achieving endemic status.

COVID-19 bivalent booster uptake has been very sluggish, even though the booster provides better protection against newer variants. What can pharmacists and their teams do to improve booster rates?

Findings by researchers at Epic, the electronic health record company, show that the benefits extend to people ages 50-64.

Although few cultures showed bacterial coinfections, many children were given antibiotics.

Additional research is needed to fully understand the scope of Long COVID.

Moderna’s bivalent mRNA COVID-19 booster reached prespecified superiority and noninferiority criteria against multiple strains of SARS-CoV-2.